Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inositol for depressive disorders.

M J Taylor1, H Wilder, Z Bhagwagar

  • 1Department of Psychiatry, University of Oxford, Neurosciences Building, Warneford Hospital, Oxford, Oxfordshire, UK, OX3 7JK.

The Cochrane Database of Systematic Reviews
|April 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating heterogeneity across autism, ADHD, and typical development using measures of cortical thickness, surface area, cortical/subcortical volume, and structural covariance.

Frontiers in child and adolescent psychiatry·2025
Same author

An exploratory study of functional brain activity associated with gross motor function improvement in children with unilateral cerebral palsy.

Developmental neurorehabilitation·2024
Same author

Healthcare organisations operating more sustainably will enhance health outcomes for patients and the public.

Public health·2024
Same author

Why we must anticipate a range of possible consequences of upcoming vape-related legislation changes in the United Kingdom.

Public health·2024
Same author

Evaluating the effect of child home safety training upon three family support practitioner groups: a mixed-methods study.

Perspectives in public health·2023
Same author

Characterisation of the UK high energy proton research beamline for high and ultra-high dose rate (FLASH) irradiation.

Biomedical physics & engineering express·2023
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

This study investigated inositol as a treatment for depression. Current evidence is insufficient to confirm its therapeutic benefit or acceptability in patients with depressive disorders.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Pharmacology

Background:

  • Depression is a significant mental health condition with various effective treatments.
  • Adjunctive therapies, such as inositol, may enhance the efficacy of existing depression treatments.

Purpose of the Study:

  • To evaluate the effectiveness of inositol in treating depression.
  • To assess the safety and tolerability of inositol treatment for depression.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) comparing inositol (monotherapy or adjunctive) with other treatments or placebo.
  • Searched major databases (CCTR, CCDANCTR, EMBASE, MEDLINE, etc.) and contacted experts for relevant studies.
  • Independent data extraction and analysis of four double-blind trials involving 141 participants.

Related Experiment Videos

Main Results:

  • Four short-term, double-blind trials with 141 participants were included.
  • No clear evidence of therapeutic benefit for inositol in depression treatment was found.
  • No significant adverse effects or issues with treatment acceptability were reported.

Conclusions:

  • The current evidence is inconclusive regarding the efficacy of inositol for depression.
  • Further research and ongoing studies are needed to clarify the role of inositol in depression management.